z-logo
open-access-imgOpen Access
Serum uric acid is an independent risk factor of worse mid- and long-term outcomes in patients with non-ST-segment elevation acute coronary syndromes
Author(s) -
Maciej Dyrbuś,
Piotr Desperak,
Marta Pawełek,
Mateusz Możdżeń,
Mariusz Gąsior,
Michał Hawranek
Publication year - 2021
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0156
Subject(s) - medicine , acute coronary syndrome , myocardial infarction , cardiology , quartile , coronary artery disease , stroke (engine) , st elevation , incidence (geometry) , population , revascularization , prospective cohort study , confidence interval , mechanical engineering , physics , environmental health , optics , engineering
The data on the association between serum uric acid (sUA) concentration and outcomes in patients with an ACS are inconsistent and do not focus on patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS). The aim of this study was to analyze an association of sUA concentration on admission and outcomes in those patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here